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ABSTRACT
Parental allele-specific expression of imprinted
genes is mediated by imprinting control regions
(ICRs) that are constitutively marked by DNA methy-
lation imprints on the maternal or paternal allele.
Mono-allelic DNA methylation is strictly required for
the process of imprinting and has to be faithfully
maintained during the entire life-span. While the reg-
ulation of DNA methylation itself is well understood,
the mechanisms whereby the opposite allele remains
unmethylated are unclear. Here, we show that in
the mouse, at maternally methylated ICRs, the pa-
ternal allele, which is constitutively associated with
H3K4me2/3, is marked by default by H3K27me3 when
these ICRs are transcriptionally inactive, leading to
the formation of a bivalent chromatin signature. Our
data suggest that at ICRs, chromatin bivalency has a
protective role by ensuring that DNA on the paternal
allele remains unmethylated and protected against
spurious and unscheduled gene expression. More-
over, they provide the proof of concept that, beside
pluripotent cells, chromatin bivalency is the default
state of transcriptionally inactive CpG island promot-
ers, regardless of the developmental stage, thereby
contributing to protect cell identity.
INTRODUCTION
Genomic imprinting is a specialized mechanism of tran-
scriptional regulation whereby a subset of mammalian
genes is expressed only from one allele, according to its
parental origin. Most of the about 150 imprinted genes
identified to date are involved in key biological processes,
such as cell proliferation, fetal and placental growth,
metabolic adaptation, as well as neurological processes and
behavior. Consequently, genomic imprinting must be cor-
rectly regulated during the entire life-span (1) and its mis-
regulation is causally involved in several growth and behav-
ioral syndromes in humans (2,3).
Genomic imprinting regulation relies on DNA methyla-
tion. Notably, all the discrete CpG-rich cis-acting regions
that control imprinted expression (imprinting control re-
gions, ICRs) overlap with a differentially methylated re-
gion (DMR) that harbors allelic DNA methylation inher-
ited from the male or female gamete (paternal andmaternal
germline DMRs) and subsequently maintained through-
out development (4). This allelic DNA methylation can be
‘read’ in different ways to ensure the appropriate tissue-
and developmental-specific allele-specific expression of en-
tire clusters of imprinted genes (5). Based on this constant
observation, and for clarity, DMRs that acquire differen-
tial DNA methylation in the germline will be called ICRs
thereafter.
Therefore, the allelic DNAmethylation signature at ICRs
is the first and necessary level of regulation that must be
tightly controlled. Specifically, besides being targeted by
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DNA methylation in a germline-specific manner, a specific
feature of ICRs is their ability to maintain an allelic-specific
methylation pattern during somatic development, including
during the peri-implantation reprogramming steps (6).
In the last years, most work focused on the identification
of the mechanisms whereby DNA methylation is brought
and maintained specifically to one of the two parental al-
leles. In the emerging model, transcriptional read-through
events and removal, or absence of the permissive H3K4me
chromatin mark act in a concerted manner to recruit the
de novo methyltransferase DNMT3A and its non-catalytic
co-factor DNMT3L to ICRs in the germline (7–9). The re-
sulting DNA methylation resists to the pre-implantation
demethylation wave thanks to the presence of the mater-
nal protein PGC7/Stella and the zing finger protein ZFP57
(10,11). Specifically, ZFP57 binding discriminates ICRs
from the thousands of other CpG islands that are methy-
lated in the germline and directly contributes to the selec-
tive protection of imprintedmethylation at ICRs against the
genome-wide pre-implantation demethylation wave (12).
After implantation, the DNA methyltransferase DNMT1
ensures the faithful maintenance of DNA methylation dur-
ing each cell cycle (13,14).
Conversely, the mechanisms whereby the opposite
parental allele remains unmethylated are less documented.
The presence of H3K4me, which is anti-correlated with
DNA methylation in mammalian genomes (15–17), might
be instrumental. Indeed, the DNMT3 family interacts
with histone H3 only when it is unmethylated on lysine 4,
suggesting that genomic sequences enriched for H3K4me
cannot recruit the de novo DNA methylation machinery
(9,18,19). This is consistent with the observation that
H3K4me2 belongs to the canonical chromatin signature of
ICRs (20). H3K4me protective role is further supported
by the observation that in pro-spermatogonia, when pa-
ternal ICRs acquire DNA methylation, maternal ICRs are
active promoters and are enriched for H3K4me3 (21,22).
RNA-DNA hybrids (R-loops) formed at active promoter
regions, as observed at the human SNRPN and murine
Airn ICRs, could also contribute to the protection against
the DNA methylation machinery (23). The finding that
single-stranded DNA efficiently recruits SET-domain
H3K4 methyltransferases (24) raises the possibility that
R-loop formation contributes to H3K4me3 accumulation.
Thus, at ICRs that are active promoters, the transcription-
ally active allele is H3K4me-enriched and protected from
DNA methylation. Nonetheless, their promoter activity
cannot explain on its own the ICR allele-specific unmethy-
lated status because this activity is often tissue- and/or
developmental-stage specific. This feature highlights the
dual constrains acting on the unmethylated allele of ICRs.
Indeed, it must be constitutively unmethylated even when
transcriptionally inactive. This suggests that a dedicated
fine-tuned regulation mechanism is required and bivalent
chromatin emerges as a relevant candidate.
Bivalent chromatin domains are unusual because histone
H3 can concomitantly be marked by the ‘active’ H3K4me
and the ‘repressive’ H3K27me3 modifications. Bivalent do-
mains were initially detected at promoters of many genes in
both human andmouse ES cells (15,25,26). In the proposed
model, bivalent chromatin domains repress gene transcrip-
tion through H3K27me3, while keeping genes ‘poised’ for
alternative fates induced by specific developmental cues.
(25). Consistently, the resolution of these bivalent domains
into either H3K4me3 or H3K27me3, as observed upon
stem cell differentiation, is believed to stably mark these re-
gions for activation or repression, respectively (16).
However, their precise role in development remains con-
troversial because probing the function of bivalent domains
in developing organisms remains a challenge (27).
Bivalency at imprinted loci has been reported at the
maternally-methylated Grb10 ICR and at the paternally-
methylated non-promoterH19 ICR (28–31). We previously
showed that the bivalent domain on the unmethylated allele
of the Grb10 ICR, which is conserved in mice and humans,
contributes to the control of its paternal brain-specific ex-
pression (28,29). Moreover, an in silico study suggested the
implication of chromatin bivalency in imprinting, although
it was conducted without taking into account the parental
origin of the analyzed histone marks and was limited to
three cell types (32).
Here, wewanted to determine whethermono-allelic chro-
matin bivalency is an ICR common signature that could
contribute to the fine-tuned regulation of imprinted gene
expression. To this purpose, we conducted a comprehensive
analysis of maternally imprinted ICRs (mat-ICRs), which,
unlike paternally imprinted ICRs, are all associated with
promoter regions, to determine their chromatin signature
relative to their transcriptional activity in different tissues.
Our main observation is that chromatin bivalency is the de-
fault state of the unmethylated allele in non-expressing tis-
sues. Our data further support a structural role for chro-
matin bivalency at ICRs by maintaining their integrity dur-
ing somatic development.
MATERIALS AND METHODS
Material collection
Material was obtained from reciprocal crosses between
C57BL/6J (B6) with Mus musculus molossinus JF1/Ms
mice, (B6xJF1) F1 and (JF1xB6) F1, respectively, referred
to as ‘BJ’ and ‘JB’ in the text. Whole embryos, placenta and
isolated brain and liver tissues were recovered at various de-
velopmental stages, as indicated in the text. MEFs were de-
rived from E13.5 carcasses.
Dnmt3L−/+ mouse embryos were obtained by crossing
homozygous Dnmt3L−/− females (129SvJae-C57BL/6 hy-
brid genetic background) withWT JF1 male mice (M. mus-
culus molossinus). E9.5 Dnmt3L−/+ conceptuses were re-
moved from pregnant mothers. Tail DNA was used for
genotype analysis by PCR as described previously (33).
ES and iMEF cell lines
The derivation and characterization of the reciprocal hybrid
ES cell lines between theM.m. domesticus strain C57BL/6J
and theM. m. molossinus strain JF1 (lines BJ1 and JB1, re-
spectively) are described in Kota et al. (39). These ES cell
lines are maintained on gelatin-coated dishes in ESGRO-
complete-plus medium (Millipore, SF001-500P) that con-
tains LIF and BMP4.
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DNA and RNA samples from the B1.3 Eed−/− and WT
ES cell lines (26) were from Amanda Fisher’s laboratory
(Lymphocyte Development Group, MRC, London, UK).
MEF cells were isolated from E13.5 Ezh2
flox/flox;ROSA26-CreERT2 mouse embryos and then
infected with the pBABE-hygro p53-DD retroviral con-
struct (addgene 9058) to generate p53-DN immortalized
MEFs (iMEFs). iMEFs were grown in Dulbecco’s modified
Eagle’s medium (Gibco, 11960-044) with 10% fetal bovine
serum (PAA, A15-101), 2 mM glutamine (PAA M11-006)
and 1% MEM Non-essential amino acids solution (Gibco
11140-035) at 37◦C in 5% CO2. For conditional Ezh2
deletion, iMEFs were incubated with 4-hydroxytamoxifen
(Sigma, T176) at a final concentration of 1 M.
JF1/Ms genome sequencing and SNP identification and val-
idation
The JF1/Ms strain was obtained from the Mammalian
Genetics Laboratory at the National Institute for Genet-
ics (Mishima, Shizuoka, Japan). Genomic DNA was ex-
tracted from the liver of a 43-week-old female using the
DNeasy Blood and Tissue kit (Qiagen, 69504). The ge-
nomic DNA library was prepared using the TruSeq DNA
Sample preparation kit (Illumina, FC-121–2001). The li-
brary (average fragment size 437 bp) was sequenced us-
ing the TruSeq SBS Kit v3 reagent (Illumina, FC-401-
3001) and the HiSeq1000 platform at the National Cen-
ter for Child Health and Development. The sequences (280
Gb in total) obtained by 100-bp paired-end sequencing
were deposited at the DNA Data Bank of Japan (DDBJ)
under the DDBJ Sequence Read Archive (DRA) acces-
sion number DRX005582 (http://trace.ddbj.nig.ac.jp/dra/
index e.html). Sequences were aligned to the mouse refer-
ence genome (mm10) using the BWA software (http://bio-
bwa.sourceforge.net/).
For each region of interest, single nucleotide variations,
insertions and deletions in the JF1/Ms genome, compared
to the reference C57BL/6J genome, were detected using
the Genome Analysis Toolkit (GATK) 1.5 (https://www.
broadinstitute.org/gatk/). Identified SNPs were validated
by direct sequencing of PCR products of the regions of
interest obtained respectively from C57BL/6J, JF1 and
C57BL/6J/JF1 liver DNA. Details of the SNPs used in this
study are given in Supplementary Table S1.
DNA extraction and bisulfite sequencing
DNA extraction was done as previously described (34).
Bisulfite conversion was performed by using the EZ DNA
methylationTM Gold Kit from Zymo (ref. D5006), accord-
ing to the manufacturer’s instruction. PCR amplifications,
cloning and sequencing were performed as previously de-
scribed (34). Details on the primers used are in Supplemen-
tary Table S1.
RNA extraction and expression analysis
Both commercial and on-site extracted RNA samples
were used in this study. To circumvent potential inter-
individual variations, quantitative gene expression anal-
yses were performed using a commercial panel of total
RNA (mouse total RNA master panel; Ozyme 636644)
obtained from pooled samples isolated from several hun-
dreds of mouse embryos and adults. For analysis of BJ
and JB material, total RNA was extracted using the Tri-
zol Reagent (Life Technologies, 15596018). After digestion
with RNase-free DNase I (Life Technologies, 180868-015),
first strand cDNA was generated by reverse transcription
with Superscript-III (Life Technologies, 18080085) using
randomized primers and 1 g of RNA. Duplicate sets of
samples were produced without reverse transcriptase to de-
tect amplification from contaminating DNA.
Allelic analysis. For each locus of interest, the parental-
allele origin of expression was assigned following direct
sequencing of the cognate RT-PCR product that encom-
passed a strain-specific SNP (SNP details in Supplementary
Table S1).
Microfluidic-based quantitative analysis. First-strand
cDNA was pre-amplified for 14 cycles with the pool of
primers used for the RT-qPCR analysis and the Taq-
Man PreAmplification Master Mix (Life Technologies,
4488593). RT-qPCRs were then performed and validated
on Fluidigm 96.96 Dynamic Arrays using the Biomark HD
system (Fluidigm Corp.) according to the manufacturer’s
instructions.
The relative gene expression was quantified using the
2−Ct method (35) that gives the fold changes in gene ex-
pression normalized to the geometrical mean of the expres-
sion of the housekeeping genes Arbp, Gapdh, Tbp and, ac-
cording to the analysis, relative to one calibrator, as indi-
cated in the text or figure legend. For each condition, the
presented data were obtained from two independent exper-
iments, each analyzed in duplicate.
RT-qPCR analyses. RNA was reverse transcribed as de-
scribed before and amplified by real-time PCRwith a SYBR
Greenmixture (Roche) using a LightCycler R© 480II (Roche)
apparatus. For each condition, analyses were repeated four
times, each in duplicate. The primer sequences are in Sup-
plementary Tables S1 and S2.
Chromatin immuno-precipitation
ChIP of native chromatin was carried out as described in
Wagschal et al. (36). Results presented in this article were
obtained from at least three and up to seven ChIP assays
performed using independent chromatin preparations, as
indicated in the figure legends. Details of the used antisera
are in Supplementary Table S3. Sequential ChIP was per-
formed as described by Bernstein et al. (25), using cross-
linked chromatin obtained from BJ1 ES cells.
Analysis of immunoprecipitated chromatin
Allelic analysis. In the input and antibody-bound frac-
tions for each antiserum used, the parental alleles were dif-
ferentiated by direct sequencing of the PCR products en-
compassing a strain-specific SNP in the regions of inter-
est (SNP details in Supplementary Table S1). For PCR
amplification (30–35 cycles, depending on the analyzed re-
gion), the HotStar Taq DNA polymerase (Qiagen, 203205)
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was used, according to the manufacturer’s recommenda-
tions. The relative allelic ratios were quantified from se-
quence files in ABI format using the Mutation quantifi-
cation module of the Mutation Surveyor R© DNA vari-
ant analysis software (Softgenetics, http://www.softgenetics.
com/mutationSurveyor.html).
Quantitative analysis. Input and antibody-bound frac-
tions were quantified by real-time PCR amplification with a
SYBR Green mixture (Roche) using a LightCycler R© 480II
(Roche) instrument. Background precipitation levels were
determined by performing mock precipitations with a non-
specific IgGantiserum (SigmaC-2288) andwere only a frac-
tion of the precipitation levels obtained with specific antis-
era. Bound/ input ratios were calculated and were normal-
ized, according to the antiserum used, against the precipi-
tation level at the Rpl30, HoxA3 and HoxD8 promoters or
IAP elements, as indicated in the figure legends. The primers
used are in Supplementary Table S2.
In silico expression analysis in Ezh2−/− somatic cells
Raw data were extracted from publicly available RNA-seq
data on E12.5 mouse cardiomyocytes (GSE 29997; 37) and
resting and activated spleen T regs (GSE58998; 38) and
plotted using R.
RESULTS
A subset of mat-ICRs is marked by mono-allelic bivalent
chromatin in ES cells
We first determined whether, besides the Grb10 ICR, other
mat-ICRs harbormono-allelic bivalent chromatin inmouse
ES cells. To this aim, we took advantage of the recently
derived reciprocal hybrid ES lines between the M. m. do-
mesticus strain C57BL/6J and the M. m. molossinus strain
JF1 (39), named BJ1 and JB1 cells, respectively. Bisulfite
analysis showed that mono-allelic, maternal DNA methy-
lation was faithfully maintained at the ICRs of these cells
in our culture conditions (Figure 1A; Supplementary Fig-
ure S1). We then performed immunoprecipitation of na-
tive chromatin (ChIP) to determine the histone modifica-
tion pattern at 14 of the 20 characterized mat-ICRs for
which we had identified SNP polymorphisms between the
C57BL/6J and JF1 strains (Supplementary Table S1). Us-
ing these polymorphisms, we analyzed the allelic enrich-
ment of H3K4me2, H3K4me3, H3K27me3 andH3K9me3.
At all tested ICRs, the unmethylated paternal allele was
marked by H3K4me2 and H3K4me3, while the methy-
lated maternal allele was associated with H3K9me3 (Fig-
ure 1A, Supplementary Figure S1). Beside this canonical
histone modification signature (reviewed in (40)), we ob-
served that H3K27me3, which marks most but not all ICRs
on the methylated allele, was also present at the unmethy-
lated allele of seven ICRs (Inpp5f-v2,Plagl1,Nnat,GnasXL,
Peg10, Nap1L5 and Igf2r). Its association with the permis-
sive marks H3K4me2 and H3K4me3 is reminiscent of the
bivalent chromatin signature (Figure 1A, Supplementary
Figure S1).
After ChIP with an anti-H3K27me3 antibody, we con-
firmed by bisulfite sequencing the presence of both the ma-
ternally methylated and the paternally unmethylated allele
of these seven ICRs in the precipitated chromatin (Supple-
mentary Figure S2). Thus, differently from most CpG is-
lands (41,42), DNA methylation and H3K27me3 can co-
exist at a subset of ICRs, as already shown in other studies
(e.g: 43–47).
Next, we observed that, unlike the other mat-ICRs, tran-
scripts initiating from ICRs with bivalent chromatin on the
paternal allele (see Supplementary Table S1 for details) were
barely or not detectable in ES cells, suggesting a repressive
structure that is homogeneously present in all cells (Fig-
ure 1B). This was further supported by in silico analysis
of the deposition of total RNA PolII and H3K64ac, a his-
tone mark associated with active promoters (48). Strikingly,
we observed that H3K64ac discriminated the mat-ICRs as-
sociated with bivalent chromatin from the transcription-
ally active mat-ICRs (Supplementary Figure S3). A similar
trend is observed for total RNA PolII, that is nonetheless
enriched at Nnat and Inpp5f-v2 ICRs suggesting a primed
configuration at these loci, a signature found, genome wide,
at 2/3 of bivalent domains (49) (Supplementary Figure
S3). Conversely, the Peg10 locus, which showed a sustained
transcription level (Figure 1B), was consistently enriched
for H3K64ac (Supplementary Figure S3). Nonetheless, se-
quential ChIP approaches, in which two successive rounds
of immunoprecipitation were performed using antibodies
against H3K4me3 and then against H3K27me3 or recipro-
cally, confirmed that these seven mat-ICRs, including the
Peg10 ICR, carried both histone modifications on their pa-
ternal unmethylated allele (Supplementary Figure S3). This
suggests that transcription occurs at Peg10 despite the pres-
ence of H3K27me3.
Combined, our observations reveal that, including
Grb10, eight mat-ICRs out of 15 studied have bivalent chro-
matin on their unmethylated paternal allele in ES cells.
Mat-ICRs associated with bivalent chromatin in ES cells
comprise tissue-specific promoters
To determine whether this bivalent chromatin signature
could be involved in the control of tissue-specific gene ex-
pression, we profiled, using a microfluidic quantitative RT-
PCR approach, the expression pattern of transcripts initi-
ating from these eight mat-ICRs regions at different stages
of mouse development and in different adult tissues. To en-
sure that the possible inter-individual variation in expres-
sion level did not interfere with the analysis, each RNA
sample was obtained from pooled samples isolated from
several hundred animals. We also included RNA obtained
from mouse embryonic fibroblasts (MEFs) derived from
C57BL/6J x JF1 (BJ) E13.5 embryos.
Transcripts initiating from these eight regions were
strongly expressed only in few tissues (Figure 2). Specif-
ically, expression of Inpp5f-v2, Nap1l5 and Grb10 (iso-
form initiating from the ICR and referred as ‘Grb10 pat-
isoform’) was almost exclusively restricted to neural tissues
(spinal cord and brain), in agreementwith the literature (e.g.
28,50,51). In addition to expression in neural tissue, Nnat,
Plagl1 and GnasXL were also strongly expressed in E11 to
E17 embryos, while Peg10 was mostly detected in placenta.
On the other hand, Airn that is not expressed in a subset
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Figure 1. Bivalent chromatin marks the unmethylated allele of a subset of maternal ICRs in ES cells. (A) Schematic representation of the analyzed ICRs
(green circles) and their position relative to the main associated gene(s). The methylation patterns are symbolized by lollipops (black: methylated; white:
unmethylated). The name of the transcripts initiating from the ICR region are also indicated. Kv-DMR is an example of an ICR with a canonical chro-
matin signature. The Inpp5f-v2 and Plagl1DMRs are examples of ICRs marked by mono-allelic bivalent chromatin. The upper panels show representative
bisulfite-based sequencing data obtained from BJ1 ES cells. Each horizontal row of circles represents the CpG dinucleotides on an individual chromosome.
Solid circles, methylated CpG dinucleotides; open circles, unmethylated CpG dinucleotides. The parental origin (Mat., maternal; Pat., paternal) was de-
termined using the indicated strain-specific SNPs. The lower panels show the data obtained by native ChIP using anti-H3-K4me2, -K4me3 and -K27me3
antibodies. These three histone marks were similarly enriched at the analyzed ICRs in BJ1 (n = 5) and JB1 (n = 1) ES cells. The precipitation level was
normalized to that obtained at the Rpl30 promoter (for H3K4me2 and H3K4me3) and at the Hoxa3 promoter (for H3K27me3). The allelic distribution
of each histone mark was determined by direct sequencing of the PCR product encompassing a strain-specific SNP in the analyzed region. The mean
values (± standard deviation) of the relative allelic ratios (Pink: maternal; Blue: paternal) are shown under representative chromatograms. H3K27me3 is
enriched only on the maternal allele at Kv-DMR and on both alleles at the Inpp5f-v2 and Plagl1 ICRs, forming thus, with H3K4me2 and H3K4me3 a
bivalent chromatin structure on the paternal unmethylated allele. (B) Microfluidic-based quantitative RT–PCR analysis of the transcripts initiating from
the 15 studied maternal ICRs in BJ1 ES cells. Results are presented as the percentage of the geometrical mean of the expression of the three housekeeping
genes Arbp, Gapdh and Tbp. Data were obtained from two independent experiments, each done in duplicate. *Grb10 pat-isoform.
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Figure 2. Developmental- and tissue-specific gene expression from mat-ICRs associated with bivalent chromatin. Microfluidic-based RT-qPCR analysis
of the transcripts initiating from the eight maternal ICRs that are marked by bivalent chromatin in ES cells. Results are presented as the fold enrichment of
the mean expression level detected in all tissues, following normalization to the geometrical mean of the expression of the three housekeeping genes Arbp,
Gapdh and Tbp. Data were obtained from two independent experiments, each analyzed in duplicate. * Grb10 pat-isoform.
of tissues was homogenously expressed, albeit at low level,
in several samples. These results show that at the eight mat-
ICRs associated with bivalent chromatin, transcripts are ex-
pressed in a tissue- and developmental-specific fashion.
Absence of H3K27me3 at the ICR’s unmethylated alleles cor-
relates with imprinted tissue-specific expression
The canonical model (25) predicts that, upon differentia-
tion, bivalent domains tend to be resolved either toward
H3K4me3 or H3K27me3, leading to stable gene expression
activation or repression, respectively. To determine whether
this scheme could apply to bivalent chromatin associated
with ICRs, we investigated their histone modifications sig-
nature in a panel of representative primary cells and tissues
(MEFs, E9.5 whole embryos, neonate brain, adult liver and
placenta) isolated from reciprocal hybrid C57Bl/6J × JF1
(BJ) and JF1 × C57Bl/6J (JB) mice. In addition to Grb10,
that we previously analyzed (28), here we conducted de-
tailed analyses at Nnat, Inpp5f-v2, Nap1L5 and Plagl1 loci,
which all possess SNPs to assess the parental origin of ex-
pression. The expression patterns (assessed by RT-qPCR)
recapitulated the results obtained with the microfluidic-
based approach. Moreover, we confirmed, using informa-
tive SNPs, the imprinted paternal expression in the express-
ing tissues (Figure 3, Supplementary Figure S4). Following
ChIP, we analyzed the allelic distribution of the H3K4me2,
H3K4me3, H3K27me3 and H3K9me3 marks. Unexpect-
edly, at most mat-ICRs, H3K4me3 was maintained irre-
spectively of the gene expression status. For instance, the
Nnat and Inpp5f-v2 DMRs showed a significant paternal
allelic enrichment of H3K4me3 in MEFs, liver and pla-
centa where they were not expressed (Figure 3, Supple-
mentary Figure S4B). Grb10 was an exception as it main-
tainedH3K4me3 only in the expressing tissues (28).We also
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Figure 3. Paternal gene expression correlates with loss of H3K27me3 on the paternal allele at bivalent chromatin-associated ICRs. The upper panel
shows representative results of gene expression in MEFs, embryos and tissues from BJ mice. Results were normalized to the expression level of the two
housekeeping genes Ppia and Rpl30. Experiments were repeated four times, each in duplicate. The parental origin of gene expression was determined
by direct sequencing of the PCR product encompassing a strain-specific SNP in the analyzed region. Lower panels: chromatin analysis following native
ChIP using anti-H3-K4me3 and -K27me3 antibodies in BJ and JB (for neonate brain and placenta) samples. The precipitation level was normalized to
that obtained at the Rpl30 promoter (for H3K4me3) and at the HoxA3 or HoxD8 promoter (for H3K27me3). The allelic distribution of each mark was
determined by direct sequencing of the PCR product encompassing a strain-specific SNP in the analyzed region. The mean values (± standard deviation)
of the relative allelic ratios (Pink: maternal; Blue: paternal) are indicated under representative chromatograms. For each tissue, values are the mean of at
least three independent ChIP experiments (n), each in duplicate: MEFs (n = 3); E9.5 embryos (n = 3); neonate brain (BJ n = 2; JB n = 2); liver (n = 3);
placenta (BJ n = 2; JB n = 1).
confirmed the previous observation that in all tissue sam-
ples and at all tested mat-ICRs, H3K4me2 was associated
with the unmethylated paternal allele, while H3K9me3 was
consistently associated with the methylated maternal allele
(Supplementary Figure S4; 20).
Strikingly, we observed that the H3K27me3 status dis-
criminated between expressing and non-expressing tissues
at all analyzed mat-ICRs carrying a bivalent domain in
ES cells, but for Plagl1 (Figure 3, Supplementary Figure
S4). For instance, at the Nnat ICR, H3K27me3 was absent
from the paternal allele only in the two expressing tissues
(E9.5 embryos and neonate brain) (Figure 3). Conversely, at
the Plagl1 ICR, H3K27me3, and thus bivalency, was main-
tained on the paternal allele in neonatal brain and placenta
where the gene was paternally expressed (Supplementary
Figure S4C). Although we cannot exclude that transcrip-
tion initiates in an H3K27me3-enriched context or through
the use of an alternative promoter, we rather believe that
this apparent discrepancy is due to expression arising froma
subpopulation of cells within these two tissues. Most of the
detected H3K27me3 enrichment would thus be explained
by the presence of non-expressing cells. In agreement with
this hypothesis, we did not detect H3K27me3 on the pa-
ternal allele of the Plagl1 ICR in MEFs in which Plagl1
is homogenously expressed. Conversely, in E9.5 embryos,
where Plagl1 expression is restricted to some tissues (52),
H3K27me3 was partially enriched on the paternal allele.
Moreover, in an in vitro system that recapitulates mouse
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neurogenesis, loss of the H3K27me3 mark from the pater-
nal allele of thePlagl1 ICR correlated with its de-repression
(DN; SMM, PA; in preparation).
Altogether these observations highlight that H3K27me3
removal correlates with tissue-specific expression from the
mat-ICRs associated with bivalent chromatin in ES cells,
while bivalency is maintained in non-expressing somatic tis-
sues.
Bivalent chromatin consistently marks mat-ICRs in non-
expressing somatic tissues
These results suggest that bivalency could contribute to
regulate tissue-specific expression at a subset of mat-ICRs.
We thus wanted to know how tissue-specific expression is
controlled at the other mat-ICRs that are not associated
with bivalent chromatin in ES cells. Microfluidic quantita-
tive RT-PCR analysis using the panel of 17 tissue/embryo
samples showed that at some of these ICRs (for instance
KvDMR and Zrsr1 (previously known as U2af1-rs1), gene
expression was widespread (Figure 4 A). Consistently, these
ICRs displayed a canonical chromatin signature in all ex-
amined tissues, with H3K4me2/me3 only on the paternal
allele, as exemplified by the KvDMR ICR (Supplementary
Figure S5). At other ICRs, paternal tissue-specific expres-
sion was observed, although the difference in the expression
level between high- and low-expressing tissues was lower
compared to what observed atmat-ICRs associated with bi-
valent chromatin in ES cells (Figure 4A, compare with Fig-
ure 2). Unexpectedly, we observed that, again, H3K27me3
enrichment discriminated between expressing (only on the
maternal allele) and non-expressing tissues (on both alle-
les). This indicates that bivalent chromatin is acquired on
the paternal allele specifically in non-expressing tissues. For
instance, the Peg3 andMest ICRs both gained H3K27me3
on the paternal allele in MEFs and liver where gene expres-
sion was repressed (Figure 4B, Supplementary Figure S6).
Collectively, our results suggest that in non-expressing
tissues, bivalent chromatinmarks the unmethylated allele of
all mat-ICRs, regardless of their chromatin signature in ES
cells. This indicates that chromatin bivalency can be gained
in somatic tissues through acquisition of H3K27me3.
Bivalent chromatin is present by default at unmethylatedmat-
ICRs
To gain insights into the link between bivalency and
gene expression at mat-ICRs, we assessed the ICR chro-
matin signature inDnmt3L−/+ E9.5 embryos obtained from
Dnmt3L−/− females, in which DNA methylation imprints
at ICRs are not established during oogenesis. In these em-
bryos, lack ofmaternalDNAmethylation at promoter ICRs
should lead to biallelic expression of the associated tran-
script. In agreement with the literature (33,34,53), this was
true for most transcripts initiating from mat-ICRs (Figure
5A, Supplementary Figure S7). Conversely, gene expression
at the Grb10 andNap1L5 ICRs, which was barely observed
in wild type (WT) embryos, was also undetectable in mu-
tant embryos (Figure 5). To investigate the molecular bases
of this DNAmethylation-independent silencing on the ma-
ternal allele, we performed ChIP analyses in WT and mu-
tant embryos. We confirmed and extended our previous ob-
servation (20) that in the absence of maternal DNA methy-
lation, allele-specific histone modification signature is lost
and both alleles of mat-ICRs adopt a paternal epigeno-
type. Accordingly, at all analyzed mat-ICRs of Dnmt3L−/+
E9.5 embryos, H3K4me2/me3 were enriched on both alle-
les and the repressive H3K9me3modification wasmarkedly
decreased on the maternal allele (Figure 5). Strikingly, un-
like the other repressive marks, H3K27me3 was maintained
at the Nap1l5 and Grb10 ICRs, while it decreased at the
other mat-ICRs (Figure 5B). Combined with the biallelic
enrichment for H3K4me2 and H3K4me3, this resulted in
the gain of bivalent chromatin also on the maternal allele
of these two transcriptionally ‘inactive’ ICRs.
These results highlight that, unlike the other repressive
marks H3K9me3 and H4K20me3 (Figure 5B and (20)),
H3K27me3 enrichment on the maternal allele of mat-ICRs
is not dependent onDNAmethylation, but rather to the ab-
sence of transcriptional activity. Collectively, our findings
suggest that chromatin bivalency is acquired by default in
transcriptionally inactive mat-ICRs.
Absence of H3K27me3 affects ICR-associated transcription
in a locus- and tissue-specific manner
Our observation that bivalency could be the default state
of inactive ICRs questions the role of H3K27me3 to dy-
namically arbitrate expression from these regions, as postu-
lated by the canonical model (25). To determineH3K27me3
functional significance at mat-ICRs, we analyzed the ex-
pression of the ICR-associated transcripts in Eed−/− ES
cells. EED is a component of the Polycomb repressive com-
plex 2 (PRC2) that mediates H3K27me3 deposition (26).
Despite the global reduction of H3K27me3 level (26), gene
expression was only mildly affected in Eed−/− ES cells com-
pared to wild type cells (Figure 6A). Specifically, gene ex-
pression was reproducibly and significantly increased only
at three loci (Grb10, Plagl1 and Nap1L5) in Eed−/− com-
pared toWT ES cells, although the expression level at these
three ‘de-repressed’ loci in mutants remained low. Indeed,
these transcripts were barely detectable inWTES cells (Fig-
ure 1) and the extent of de-repression (from 2.9- to 5.8 -fold
higher) never reached the level observed in somatic tissues.
This observation indicates that in Eed−/− ES cells, loss of
H3K27me3 leads to a limited and locus-specific transcrip-
tion de-repression at bivalent mat-ICRs. This is consistent
with a recent study showing that in mouse ES cells deficient
in PRC2, only a very small subset of PRC2-target genes are
aberrantly expressed (54).
To determine whether this mild effect occurred also in
differentiated cells, we analyzed expression in immortal-
ized MEF (iMEF) cells deficient for EZH2, the enzyme of
the PRC2 complex that catalyzes H3K27me3. Compared
with WT iMEFs, H3K27me3 was markedly decreased at
mat-ICRs in Ezh2−/− iMEF cells (Supplementary Figure
S8B). However, analysis of the expression of seven ICR-
associated transcripts showed that only the expression of
three (Airn, Nnat and Mest) was increased in Ezh2−/−
iMEFs compared with WT iMEFs, where they were all
barely or not detectable (Figure 6B). We next analyzed
publicly available RNA-seq data concerning Ezh2−/− car-
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Figure 4. Chromatin bivalency marks mat-ICRs in non-expressing tissues. (A) Microfluidic-based RT-qPCR analysis of the transcripts initiating from the
seven mat-ICRs that are not marked by bivalent chromatin in ES cells. Results are presented as fold enrichment of the mean expression level detected in
all tissues, after normalization to the geometrical mean of the expression of the three housekeeping genes Arbp, Gapdh and Tbp. Data were obtained from
two independent experiments, each analyzed in duplicate. (B) Gene expression and chromatin analysis. Details of the legend are as in Figure 3. The Peg3
ICR is shown as an example of ICR with tissue-specific promoter activity. The allelic distribution of histone marks was determined by direct sequencing
of the PCR product encompassing a strain-specific SNP in the analyzed region. Representative data obtained in BJ samples are shown. The mean values
(± standard deviation) of the relative allelic ratios (pink: maternal; Blue: paternal) are given. Chromatin bivalency, which is absent in ES cells, is gained in
non-expressing tissues through H3K27me3 acquisition on the paternal allele.
diomyocytes (37) and spleen regulatory T-cells (Tregs) (38).
By focusing our analysis onmat-ICR-associated transcripts
that are poorly expressed in WT cells, we observed a very
limited and tissue-specific de-repression effect. For instance,
Peg10 transcription was partially de-repressed in Ezh2−/−
cardiomyocytes, but not in spleen Tregs (Figure 6C). Simi-
larly,Nap1L5, which was deregulated inmutant ES cells, re-
mained unexpressed in Ezh2−/− cardiomyocytes and Tregs
(Figure 6C). This is reminiscent of our previous observation
that in Eed−/− 6.5 dpc embryos, which lack the PRC2 com-
plex, ectopic paternal expression of Grb10 was limited to
one part of the extra-embryonic ectoderm only, while unaf-
fected in the remaining of the embryo ((28), Supplementary
Figure S9).
Absence of allelic polymorphisms in Eed−/− ES cells and
Ezh2−/− iMEF cells did not allow us to draw formal con-
clusions about the parental origin of the ‘de-repressed’ tran-
scripts. Nevertheless, bisulfite analysis showed that DNA
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Figure 5. Chromatin bivalency is present at both parental alleles of transcriptionally inactive mat-ICRs in Dnmt3L−/+ embryos. Details of the molecular
analyses at ICRs in WT and Dnmt3l−/+ E9.5 embryos. Mest and Nnat are representative examples of transcriptionally active and Nap1L5 and Grb10 of
transcriptionally inactive ICRs in WT embryos. (A) Transcriptional analysis using pools of at least 15 WT or mutant embryos. Results are presented as the
percentage of expression relative to the geometrical mean of the expression of the two housekeeping genes Ppia and Rpl30. Data are from two independent
experiments, each analyzed in duplicate. No expression was detected from the Nap1l5 and Grb10 ICRs (no Ct) in both WT and mutant conceptuses.
The parental origin of expression from theMest and Nnat ICRs was determined by direct sequencing of the PCR product encompassing a strain-specific
SNP in the analyzed region (* Grb10 pat-isoform). (B) Chromatin analysis following native ChIP with anti-H3-K4me2, -K4me3, -K27me3 and -K9me3
antibodies. The precipitation level was normalized to that obtained at the Rpl30 promoter (for H3K4me2 and H3K4me3), IAP (for H3K9me3) and the
Hoxa3 promoter (for H3K27me3). The allelic distribution of these marks was determined by direct sequencing of the PCR product encompassing a strain-
specific SNP in the analyzed region. The mean values (± standard deviation) of the relative allelic ratios (pink: maternal; blue: paternal) are indicated
under representative chromatograms. Values are the mean of three independent ChIP experiments, each analyzed in duplicate.
methylation at ICRs was similar in WT and mutant cells
(Supplementary Figure S8). The detected transcripts were
thus likely to originate from the unmethylated paternal al-
lele.
Together these findings indicate that absence of
H3K27me3 only partially affects the expression of
ICR-associated transcripts in a locus- and tissue-specific
manner.
DISCUSSION
The main observation of this study is that H3K27me3 and
consequently bivalent chromatin are acquired on the un-
methylated allele of mat-ICRs when they are transcription-
ally inactive, regardless of the developmental stage or tissue
analyzed. Besides suggesting that bivalent chromatin con-
tributes to the fine-tuned regulation of genomic imprinting,
this finding provides the proof of concept that the recruit-
ment by default of PRC2 to non-transcribed CpG-island
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Figure 6. Absence of H3K27me3 affects ICR-associated transcript expres-
sion in a locus- and tissue-specific manner. (A and B) Transcription from
mat-ICRs associated with bivalent chromatin is mildly affected and only
in a subset of loci in Eed−/− ES cells (A) and Ezh2 -/- iMEF cells (B). The
results ofRT-qPCRanalyses are presented as the fold enrichment of the ex-
pression level obtained inEed+/+ ES andEzh2 +/+ iMEF cells, respectively.
Data are from four independent experiments, each analyzed in duplicate.
(C) Transcription from maternal ICRs associated with bivalent chromatin
in Ezh2−/− somatic cells. Publicly available RNA-seq data were used to
produce scatter plots to correlate genome-wide the normalized expression
between heterozygotes controls (Het Ezh2 fl) andEzh2mutant (KoEzh2 fl)
E12.5 cardiomyocytes, resting (CD62Lhi) and activated (CD62Llo) spleen
T regulatory cells (Tregs). Transcripts initiating from the ICRs are shown
by red dots. Peg10 expression is partly affected in Ezh2−/− cardiomocytes,
but not in Ezh2−/− Tregs cells compared to controls (Ezh2+/- cells).
genes, so far described only in pluripotent cells (54,55), can
also occur in somatic lineages.
Initially, it was hypothesized that bivalent chromatin was
a pluripotency-associated feature to poise genes for activa-
tion or repression upon differentiation (25). Consistently,
widespread resolution of bivalency has been observed upon
ES cell differentiation, although some loci retain bivalency,
indicating that non-pluripotent cells can also contain biva-
lent domains (16,56). The genome-wide dynamics of chro-
matin bivalency upon differentiation was studied in an in
vitro model of neurogenesis in which stem cells differenti-
ate into neuronal progenitors and finally into glutamater-
gic pyramidal neurons (17). Strikingly, the authors observed
that several hundred ‘de novo’ bivalent domains are gained
in neural progenitors and again upon terminal differentia-
tion. Our findings in mat-ICRs also support the hypothe-
sis that chromatin bivalency is not limited to ES cells and
further confirm that this chromatin signature can be ac-
quired at all development stages. This is well-illustrated, for
instance, by theMest and Peg3 ICRs that are transcription-
ally active in ES cells and that acquire bivalency in non-
expressing somatic tissues.
However, at mat-ICRs this gain relies on acquisition of
the H3K27me3mark only. Indeed, we observed that the pa-
ternal unmethylated allele of ICRs is marked by H3K4me3
at most developmental stages, regardless of their transcrip-
tional activity, and further confirmed the constitutive en-
richment for H3K4me2 (20). Consequently, we did not find
an H3K27me3-only signature, as observed at other biva-
lent genes, following resolution toward transcription repres-
sion (16). Genome-wide studies suggest that this feature is
probably not limited to ICRs, but rather linked to the CpG-
richness of the region. Most CpG island promoters indeed
show enrichment for H3K4me2 and H3K4me3, regardless
of the associated transcriptional activity and the cell differ-
entiation state (16,17,57).
Recent studies have shown that in ES cells, H3K4me3
at bivalent promoters is controlled by MLL2, one of six
SET1/trithorax-type H3K4methyltransferases (58,59) that
are thought to be recruited to unmethylated CpG islands
without assistance of transcription factors (59). One might
expect that MLL2, which is widely expressed during de-
velopment and in adult tissues (60), could also account
for the maintenance of the H3K4me2/3 marks at bivalent
domain-associated ICRs in somatic tissues. Themechanism
involved in establishing the PRC2-mediated H3K27me3 re-
mains more elusive because this complex does not con-
tain any DNA binding domain (27). In the traditional ‘in-
structive model’, supported by several studies, transcrip-
tion factors or long non-coding RNAs are instrumental
in promoting PCR2 recruitment to chromatin (e.g. 61,62).
However, this model hardly accounts for the observation
that bivalency is the default chromatin signature at artifi-
cially introduced CpG islands in ES cells (63–65). A sec-
ond model (‘responsive model’) predicts that PRC2 recruit-
ment is responsive to permissive chromatin signatures at
CpG islands (55). A recent elegant study supports this hy-
pothesis by showing that, in ES cells, PRC2 is recruited
by default at transcriptionally inactive CpG islands (54).
The recent discovery that the hierarchical model whereby
PRC1 is recruited in a PRC2-dependent manner might
be reversed further provides a mechanism to explain the
establishment of H3K27me3 by default. In the emerging
model, a CxxC domain-containing factor that specifically
recognizes unmethylated DNA, such as KDM2B, recruits
PRC1 to unmethylated and transcriptionally inactive CpG
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Figure 7. Model of the fine-tuned regulation of imprinted gene expression by chromatin bivalency. Model illustrating the gain and loss of chromatin
bivalency at maternal ICRs during development. Relative to their transcriptional activity, the ICR paternal allele can be associated (right panel) or not
(left panel) with bivalent chromatin in pluripotent cells (early developmental stages). This signature will be maintained, upon differentiation, in lineage
sharing the same transcriptional status (late developmental stages). During lineage commitment, in the absence of transcriptional activity or transcription
below a certain threshold, H3K27me3 is deposited by default on the paternal allele, already marked by H3K4me2/3, thus leading to the formation of a
bivalent domain (from left to lower central panel). This signature, by repelling DNA methylation and protecting against spurious expression, contributes
to protecting the ICR integrity in non-expressing cells. Conversely, the switch from gene repression to expression, upon lineage commitment, might rely on
the availability of the ad hoc transcription machinery associated with H3K27me3 removal. Specific co-factors, for instance H3K27me3 demethylases, could
counteract PRC1/2 action and ensure robust transcription from the paternal allele (from right to upper central panel). DNA methylation is represented
by filled lollipops. Arrows indicate active transcription.
islands, leading to H2AK119ub1 deposition. Subsequently
this modification will recruit PRC2, by a yet to be estab-
lished mechanism, to ultimately catalyze H3K27me3 depo-
sition at CpG islands (66–69).
Our study provides the proof of concept that the ‘respon-
sive model’, so far supported by experiments in ES cells
and, in part, using artificially introduced CpG islands, can
also apply in vivo and during the key developmental pro-
cess that is genomic imprinting. A broader characterization
of the epigenetic signature of ICRs in a panel of expressing
and non-expressing tissues, relative to H2AK119ub1 pres-
ence for instance, could provide clues about the underlying
mechanism.
The deposition by default of H3K27me3 at ICRs in
non-expressing tissues challenges the expected role of bi-
valency to arbitrate gene expression upon differentiation
and development. In PRC2 deficient cells and tissues, we
observed that gene transcription was increased only in a
subset of mat-ICRs and only slightly, further supporting
the hypothesis that H3K27me3 removal on its own is not
sufficient to trigger sustained transcription de-repression at
ICRs. Also, removal of H3K27me3 in ES cells has a limited
transcriptional impact genome-wide (54). Similarly, loss of
H3K4me3 at bivalent domains in ES cells lacking MLL2
has a very mild effect on the expression of the associated
genes upon differentiation (58,59).
Altogether, these findings indicate that the function of
chromatin bivalency is much less dynamic than expected
based on the canonical model. Our observations rather sug-
gest that the primary role of bivalency is rather protective
at maternally methylated ICRs to ensure that the paternal
allele remains unmethylated, although repressed in a sub-
set of tissues. Specifically, in our working hypothesis, ab-
sence of transcriptional activity or transcription below a
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certain threshold is sufficient to allow PRC1/2 recruitment
to the paternal unmethylated allele of ICRs and the sub-
sequent deposition of H3K27me3 in somatic lineages (Fig-
ure 7). By contrast H3K4me2 and possibly also H3K4me3
are maintained during the entire development in all somatic
lineages through MLL2, when present in a bivalent con-
figuration, and by another transcription factor-associated
MLL/SET1 complex at transcriptionally active ICRs. Im-
portantly, as the DNA methylation complex is repelled
by H3K4me2/3 (9,70), this configuration ensures that the
paternal allele of mat-ICRs remains unmethylated during
development. Concomitantly, H3K27me3 protects against
spurious and unscheduled transcription that could initiate
in non-expressing tissues that partially share the pool of
transcription factors found in expressing tissues but unable
to sustain an appropriate expression level (Figure 7). This
model highlights that two silencing mechanisms are func-
tional at ICRs in an allele-specific fashion. The first one, on
thematernal allele, is constitutive and relies onDNAmethy-
lation and repressive histone marks. The second one, based
on bivalency, contributes to the appropriate tissue-specific
expression from the paternal allele.
According to this model, the switch from gene repres-
sion to expression during lineage commitment would rely
on transcription-induced loss of H3K27me3 at ICRs, as
suggested by the loss of H3K27me3 at the expressed al-
lele, but not from the silent maternally methylated allele.
Although the underlying mechanism remains elusive, one
might hypothesize that in the lineage possessing the ad hoc
transcription factors, the assembled transcription machin-
ery might trigger the loss of H3K27me3, by recruiting hi-
stone demethylases, for instance, and then ensure a robust
transcription. Further analyses at ICRs in a controlled sys-
tem of cell/tissue differentiation should provide insights on
this mechanism andmore broadly on the control of bivalent
domain resolution during lineage commitment.
Finally, our observation is also relevant for understand-
ing the molecular bases of imprinting disorders. Genetic
alterations (such as uniparental disomy, chromosome im-
balance and point mutations) or abnormal DNA methyla-
tion at ICRs are causally linked to most imprinting disor-
der cases; however, some phenotypically well-characterized
patients do no display any of these molecular defects. This
is observed for instance in ∼10% of patients with Angel-
man syndrome, a severe neurobehavioral disorder, and in
40% of patients with Silver-Russell syndrome, a pre- and
postnatal growth disorder. Alteration in the control of biva-
lency at ICRs could help understanding these cases. Indeed,
the tissue- and locus-specific effects we observed in PRC2-
deficient samples suggests that aberrant loss of H3K27me3
at ICRs could contribute to the somatic mosaicism and to
the heterogeneous clinical features widely documented in
these pathologies (71).
Our study shows that chromatin bivalency contributes
to the fine-tuned regulation of imprinted gene expression.
Specifically, we propose that it plays primarily a safe-
guard function to ensure that the paternal allele of ma-
ternal ICRs remains constitutively unmethylated, while be-
ing firmly silent in a subset of tissues. In addition, its de-
velopmentally controlled resolution, through the loss of
H3K27me3, ensures robust gene expression in the appro-
priate cell types and developmental stages. Beyond imprint-
ing, our study provides the proof of concept that bivalency
can be the default state of transcriptionally inactive CpG
islands/promoters, regardless of the developmental stage.
This raises the question of whether the protective model we
hypothesized at ICRs could be extended genome-wide to
protect cell identity.
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